TRIB Trinity Biotech plc

6.750USD-5.59%Mkt Cap: 5.49M $P/E: —

Trinity Biotech plc, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the …

Key Statistics

Company
Market Cap5.49M USD
Enterprise Value137.67M USD
Revenue (TTM)43.78M USD
Gross Profit16.89M USD
Net Income (TTM)-37.38M USD
Revenue/Share70.71 USD
Last Price6.750 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees287
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-6.94
PEG0.30
EV/EBITDA-16.70
EV/Revenue3.14
P/S0.13
P/B-0.06
EPS (TTM)-60.00
EPS (Forward)-1.03
52W Range
0.310046% of range14.17
52W High14.17 USD
52W Low0.3100 USD
Profitability
Gross Margin38.57%
Oper. Margin-9.98%
EBITDA Margin-18.83%
Profit Margin-85.36%
ROE51.92%
ROA-35.54%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.93M USD
CapEx (TTM)6.22M USD
FCF Margin-25.57%
FCF Yield-203.98%
Net Debt132.85M USD
Net Debt/EBITDA-16.12
Balance Sheet
Debt/Equity-1.92
Current Ratio0.25
Quick Ratio0.11
Book Value/Sh-115.42 USD
Cash/Share7.61 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield1.13%
Payout Ratio0.00%
Ex-Div DateJun 5, 2015
Pay DateJul 1, 2015
Splits
Last Split1:30
Split DateJul 24, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.813.13K
Float555.43K
Insiders13.81%
Institutions4.07%
Short Interest
Short Ratio0.3d
Short % Float2.52%
Short % Out.0.98%
Shares Short8.00K
Short (prev mo.)9.28K
Technical
SMA 509.458 (-28.6%)
SMA 20017.15 (-60.6%)
Beta0.97
S&P 52W Chg15.78%
Avg Vol (30d)17.82K
Avg Vol (10d)7.06K
Technical Indicators
RSI (14)42.4
MACD-0.7116
MACD Signal-0.7076
MACD Hist.-0.0040
BB Upper9.028 USD
BB Middle7.169 USD
BB Lower5.310 USD
BB Width51.86%
ATR (14)0.8679 USD
Vol Ratio (20d)0.73x